Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice (Q42230180)

19 October 2017

Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice (English)

1 reference

19 October 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Joaquín Cabezas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Gloria Sanchez Antolin

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Federico Sáez-Royuela

9

object named as

Federico Sáez-Royuela

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

Begoña Sacristán

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

José L Olcoz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ramón Pérez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Juan De la Vega

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Rosa García

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Félix García-Pajares

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

José M González

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Felipe Jiménez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Santiago Rodríguez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Antonio Cuadrado

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

María J López-Arias

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Isidro García

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ana Milla

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Emilia García-Riesco

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

María Muñoz

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Francisco Jorquera

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

9 April 2014

1 reference

19 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

401-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

Evolving epidemiology of hepatitis C virus

10 June 2020

cites work

1 reference

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

21 January 2018

1 reference

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

21 January 2018

1 reference

Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.

21 January 2018

1 reference

Predictors of treatment in patients with chronic hepatitis C infection - role of patient versus nonpatient factors

21 January 2018

1 reference

A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care

21 January 2018

1 reference

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting

21 January 2018

1 reference

Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents.

21 January 2018

1 reference

Market uptake of new antiviral drugs for the treatment of hepatitis C.

21 January 2018

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

Boceprevir for previously treated chronic HCV genotype 1 infection

21 January 2018

1 reference

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection

21 January 2018

1 reference

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C.

21 January 2018

1 reference

[Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)].

21 January 2018

1 reference

Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients

21 January 2018

1 reference

Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection.

21 January 2018

1 reference

Boceprevir: a review of its use in the management of chronic hepatitis C genotype 1 infection

21 January 2018

1 reference

Rate and predictors of treatment prescription for hepatitis C.

21 January 2018

1 reference

Reasons for non-treatment of hepatitis C in veterans in care

21 January 2018

1 reference

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

21 January 2018

1 reference

Virus C cure as a motivation for strong lifestyle change?

21 January 2018

1 reference

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

Update on the management and treatment of hepatitis C virus infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program Office

21 January 2018

1 reference

A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir.

21 January 2018

1 reference

Predicted effects of treatment for HCV infection vary among European countries

21 January 2018

1 reference

Data to guide the "test and treat era" of hepatitis C.

21 January 2018

1 reference

Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24650000%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference